The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.
2.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
3.
PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.
4.
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted
5.
Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?
1.
Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management
2.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
Updates on the First Line Management of ALK+ NSCLC
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation